Cargando…

Magnitude of tuberculosis lymphadenitis, risk factors, and rifampicin resistance at Adama city, Ethiopia: a cross-sectional study

Mycobacterium tuberculosis complex has an impact on public health and is responsible for over one million deaths per year. Substantial numbers of people infected with M. tuberculosis can develop tuberculosis lymphadenitis; however, there is a limited study in Adama, Ethiopia. The aim of this study w...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumbi, Hawi, Reda, Dawit Yihdego, Solomon, Manyahlehal, Teklehaimanot, Alemwosen, Ormago, Moges Desta, Ali, Musa Mohammed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10518321/
https://www.ncbi.nlm.nih.gov/pubmed/37743370
http://dx.doi.org/10.1038/s41598-023-43206-7
_version_ 1785109487516909568
author Kumbi, Hawi
Reda, Dawit Yihdego
Solomon, Manyahlehal
Teklehaimanot, Alemwosen
Ormago, Moges Desta
Ali, Musa Mohammed
author_facet Kumbi, Hawi
Reda, Dawit Yihdego
Solomon, Manyahlehal
Teklehaimanot, Alemwosen
Ormago, Moges Desta
Ali, Musa Mohammed
author_sort Kumbi, Hawi
collection PubMed
description Mycobacterium tuberculosis complex has an impact on public health and is responsible for over one million deaths per year. Substantial numbers of people infected with M. tuberculosis can develop tuberculosis lymphadenitis; however, there is a limited study in Adama, Ethiopia. The aim of this study was to determine the magnitude of Tuberculosis lymphadenitis, its predictors, and rifampicin-resistance gene-positive M. tuberculosis. A total of 291 patients with enlarged lymph nodes were recruited from May 2022 to August 30 at Adama Comprehensive Specialized Hospital Medical College (ACSHMC). GeneXpert, Ziehl–Neelsen staining, and cytology were used for the diagnosis of TB lymphadenitis from the Fine Needle Aspirate (FNA) specimen. Rifampicin-resistant gene was detected using GeneXpert. For data entry and analysis, Epi Data version 3.0 and SPSS version 25 were used respectively. A binary logistic regression model was used to identify predictors of TB lymphadenitis. A p < 0.05 with a 95% confidence interval (CI) was taken as a cut point to determine the significant association between dependent and independent variables. The prevalence of TB lymphadenitis using GeneXpert, Ziehl–Neelsen staining, and cytology were 138 (47.4%) (95% CI 41.70–53.10), 100 (34.4%) (95% CI 28.94–39.85), and 123 (42.3%) (95% CI 36.63–47.00) respectively. Nine (3.1%) participants were infected with rifampicin-resistant gene-positive M. tuberculosis. Out of the total M. tuberculosis detected by GeneXpert (n = 138), 9 (6.5%) were positive for rifampicin resistance-gene. Participants with a chronic cough had 2 times odds of developing TB lymphadenitis (AOR: 2.001, 95% CI 1.142–3.508). Close to half of patients with enlarged lymph nodes were positive for M. tuberculosis by the GeneXpert method in the study area. Chronic cough was significantly associated with TB lymphadenitis. Rifampicin-resistant gene-positive M. tuberculosis was relatively prevalent among patients with enlarged lymph node in the study area.
format Online
Article
Text
id pubmed-10518321
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-105183212023-09-26 Magnitude of tuberculosis lymphadenitis, risk factors, and rifampicin resistance at Adama city, Ethiopia: a cross-sectional study Kumbi, Hawi Reda, Dawit Yihdego Solomon, Manyahlehal Teklehaimanot, Alemwosen Ormago, Moges Desta Ali, Musa Mohammed Sci Rep Article Mycobacterium tuberculosis complex has an impact on public health and is responsible for over one million deaths per year. Substantial numbers of people infected with M. tuberculosis can develop tuberculosis lymphadenitis; however, there is a limited study in Adama, Ethiopia. The aim of this study was to determine the magnitude of Tuberculosis lymphadenitis, its predictors, and rifampicin-resistance gene-positive M. tuberculosis. A total of 291 patients with enlarged lymph nodes were recruited from May 2022 to August 30 at Adama Comprehensive Specialized Hospital Medical College (ACSHMC). GeneXpert, Ziehl–Neelsen staining, and cytology were used for the diagnosis of TB lymphadenitis from the Fine Needle Aspirate (FNA) specimen. Rifampicin-resistant gene was detected using GeneXpert. For data entry and analysis, Epi Data version 3.0 and SPSS version 25 were used respectively. A binary logistic regression model was used to identify predictors of TB lymphadenitis. A p < 0.05 with a 95% confidence interval (CI) was taken as a cut point to determine the significant association between dependent and independent variables. The prevalence of TB lymphadenitis using GeneXpert, Ziehl–Neelsen staining, and cytology were 138 (47.4%) (95% CI 41.70–53.10), 100 (34.4%) (95% CI 28.94–39.85), and 123 (42.3%) (95% CI 36.63–47.00) respectively. Nine (3.1%) participants were infected with rifampicin-resistant gene-positive M. tuberculosis. Out of the total M. tuberculosis detected by GeneXpert (n = 138), 9 (6.5%) were positive for rifampicin resistance-gene. Participants with a chronic cough had 2 times odds of developing TB lymphadenitis (AOR: 2.001, 95% CI 1.142–3.508). Close to half of patients with enlarged lymph nodes were positive for M. tuberculosis by the GeneXpert method in the study area. Chronic cough was significantly associated with TB lymphadenitis. Rifampicin-resistant gene-positive M. tuberculosis was relatively prevalent among patients with enlarged lymph node in the study area. Nature Publishing Group UK 2023-09-24 /pmc/articles/PMC10518321/ /pubmed/37743370 http://dx.doi.org/10.1038/s41598-023-43206-7 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Kumbi, Hawi
Reda, Dawit Yihdego
Solomon, Manyahlehal
Teklehaimanot, Alemwosen
Ormago, Moges Desta
Ali, Musa Mohammed
Magnitude of tuberculosis lymphadenitis, risk factors, and rifampicin resistance at Adama city, Ethiopia: a cross-sectional study
title Magnitude of tuberculosis lymphadenitis, risk factors, and rifampicin resistance at Adama city, Ethiopia: a cross-sectional study
title_full Magnitude of tuberculosis lymphadenitis, risk factors, and rifampicin resistance at Adama city, Ethiopia: a cross-sectional study
title_fullStr Magnitude of tuberculosis lymphadenitis, risk factors, and rifampicin resistance at Adama city, Ethiopia: a cross-sectional study
title_full_unstemmed Magnitude of tuberculosis lymphadenitis, risk factors, and rifampicin resistance at Adama city, Ethiopia: a cross-sectional study
title_short Magnitude of tuberculosis lymphadenitis, risk factors, and rifampicin resistance at Adama city, Ethiopia: a cross-sectional study
title_sort magnitude of tuberculosis lymphadenitis, risk factors, and rifampicin resistance at adama city, ethiopia: a cross-sectional study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10518321/
https://www.ncbi.nlm.nih.gov/pubmed/37743370
http://dx.doi.org/10.1038/s41598-023-43206-7
work_keys_str_mv AT kumbihawi magnitudeoftuberculosislymphadenitisriskfactorsandrifampicinresistanceatadamacityethiopiaacrosssectionalstudy
AT redadawityihdego magnitudeoftuberculosislymphadenitisriskfactorsandrifampicinresistanceatadamacityethiopiaacrosssectionalstudy
AT solomonmanyahlehal magnitudeoftuberculosislymphadenitisriskfactorsandrifampicinresistanceatadamacityethiopiaacrosssectionalstudy
AT teklehaimanotalemwosen magnitudeoftuberculosislymphadenitisriskfactorsandrifampicinresistanceatadamacityethiopiaacrosssectionalstudy
AT ormagomogesdesta magnitudeoftuberculosislymphadenitisriskfactorsandrifampicinresistanceatadamacityethiopiaacrosssectionalstudy
AT alimusamohammed magnitudeoftuberculosislymphadenitisriskfactorsandrifampicinresistanceatadamacityethiopiaacrosssectionalstudy